Logo UHasselt



About EpiPose

Logo UHasselt Universiteit Hasselt - Knowledge in action


EpiPose is the acronym for: Epidemic intelligence to minimize 2019-nCoV’s public health, economic and social impact in Europe. 

The project received funding (€ 4 548 391,25) from the European Union’s Research and Innovation Action under the H2020 work programme (grant agreement number ID: 101003688, https://cordis.europa.eu/project/id/101003688)


Introducing EpiPose

Hear Communication Manager Anna Carnegie provide an overview the project

The consortium consists of 6 partners in 5 countries (BE, NL, UK, CH, IT) who provide complementary expertise in mathematical and statistical modelling of infectious diseases, participatory surveillance systems, living systematic reviews, and health economic analysis and have a strong international public health network.

The project is coordinated by Prof. Niel Hens and his team at UHasselt, Belgium.

 For more information about the participating organisations, you can visit their websites:

The project is coordinated by Prof. Niel Hens and his team at UHasselt, Belgium.

Here, Prof. Hens discusses the origins of EpiPose and his ambitions for the project.

Here, Prof. Hens discusses the origins of EpiPose and his ambitions for the project.

Main expected outcomes: 
Outcome 1: increased social and behavioural insights and preparedness
We collect data on changes in people’s awareness, perceptions, social contacts and health condition during the course of the COVID-19 pandemic. This data is essential to assess efficiency of interventions and public health messaging and how people adhere to and cope with them.

Outcome 2: increased epidemiological insights and preparedness
We assess key epidemiological parameters in various countries and their change due to intervention measures through the development of robust statistical and mathematical models for epidemic nowcasting and forecasting.

Outcome 3: increased health and macro-economic insights and preparedness
We assess the COVID-19 disease burden, impact of the pandemic and intervention strategies on financial markets, economic transactions, health costs and other indicators and of cost-effectiveness of treatments when they become available.

Project details
EpiPose aims to provide urgently needed answers about the epidemiological characteristics of 2019-nCoV, the social dynamics of the outbreak, and the related public health preparedness and response to the ongoing pandemic, also assessing the economic impact of the pandemic. EpiPose aims to deliver results quickly, according to the following objectives: 

  1. To collect and share epidemiological data of 2019-nCoV as widely as possible; 
  2. To provide country-specific estimates of key epidemiological parameters; 
  3. To model the expect impact of 2019-nCoV on morbidity and mortality; 
  4. To monitor awareness and behavioural change during the 2019-nCoV pandemic; 
  5. To provide health economic analyses for interventions within the EU; 
  6. To foster the interaction between the scientific community, public health agencies and the public EpiPose aims to make all research data, code, tools and results publicly available and its dissemination plan targets active communication and interaction with policy makers, other scientific groups and the general public. 

As such, the epidemic intelligence provided by EpiPose will help minimize the 2019-nCoV’s public health, economic and social impact.


The EpiPose team 
Prof Niel Hens: Niel is a biostatistician and mathematical epidemiologist at UHasselt with over 15 years of experience in human epidemiology and an established international expert in infectious disease modelling. Niel uses and develops mathematical and statistical methods to improve the understanding of infectious disease epidemiology. He participated in the EU FP6 project called POLYMOD on collecting social contact data relevant for the spread of infectious diseases. In 2016, Hens received a consolidator grant from the European Research Council for the project TransMID which focuses on the development of novel methods to estimate key epidemiological parameters from both serological and social contact data.

Contact us
Dr. Sarah Vercruysse: sarah.vercruysse@uhasselt.be 
Dr. Bieke Vanhoutte: bieke.vanhoutte@uantwerpen.be 
Anna Carnegie: anna.carnegie@lshtm.ac.uk


Follow us on social media:
@EpiPose on Twitter